Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Is there an association between peripheral immune markers and structural/functional neuroimaging findings?

Frodl T, Amico F.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:295-303. doi: 10.1016/j.pnpbp.2012.12.013. Epub 2013 Jan 11. Review.

PMID:
23313563
2.

Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesity.

Val-Laillet D, Aarts E, Weber B, Ferrari M, Quaresima V, Stoeckel LE, Alonso-Alonso M, Audette M, Malbert CH, Stice E.

Neuroimage Clin. 2015 Mar 24;8:1-31. doi: 10.1016/j.nicl.2015.03.016. eCollection 2015. Review.

3.

The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia.

Na KS, Jung HY, Kim YK.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:277-86. doi: 10.1016/j.pnpbp.2012.10.022. Epub 2012 Nov 1. Review.

PMID:
23123365
4.

The efficacy of a voxel-based morphometry on the analysis of imaging in schizophrenia, temporal lobe epilepsy, and Alzheimer's disease/mild cognitive impairment: a review.

Kakeda S, Korogi Y.

Neuroradiology. 2010 Aug;52(8):711-21. doi: 10.1007/s00234-010-0717-2. Epub 2010 May 22. Review.

PMID:
20495793
5.

APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer's disease.

Reinvang I, Espeseth T, Westlye LT.

Neurosci Biobehav Rev. 2013 Sep;37(8):1322-35. doi: 10.1016/j.neubiorev.2013.05.006. Epub 2013 May 20. Review.

6.

Diffusion tensor imaging of white matter degeneration in Alzheimer's disease and mild cognitive impairment.

Amlien IK, Fjell AM.

Neuroscience. 2014 Sep 12;276:206-15. doi: 10.1016/j.neuroscience.2014.02.017. Epub 2014 Feb 27. Review.

PMID:
24583036
7.

White matter abnormalities associated with Alzheimer's disease and mild cognitive impairment: a critical review of MRI studies.

Radanovic M, Pereira FR, Stella F, Aprahamian I, Ferreira LK, Forlenza OV, Busatto GF.

Expert Rev Neurother. 2013 May;13(5):483-93. doi: 10.1586/ern.13.45. Review.

PMID:
23621306
8.

Stress regulation in the central nervous system: evidence from structural and functional neuroimaging studies in human populations - 2008 Curt Richter Award Winner.

Pruessner JC, Dedovic K, Pruessner M, Lord C, Buss C, Collins L, Dagher A, Lupien SJ.

Psychoneuroendocrinology. 2010 Jan;35(1):179-91. doi: 10.1016/j.psyneuen.2009.02.016. Review.

PMID:
19362426
9.

Cytokines, prostaglandins and nitric oxide in the regulation of stress-response systems.

Gądek-Michalska A, Tadeusz J, Rachwalska P, Bugajski J.

Pharmacol Rep. 2013;65(6):1655-62. Review.

10.

Voxelwise meta-analysis of gray matter anomalies in Alzheimer's disease and mild cognitive impairment using anatomic likelihood estimation.

Yang J, Pan P, Song W, Huang R, Li J, Chen K, Gong Q, Zhong J, Shi H, Shang H.

J Neurol Sci. 2012 May 15;316(1-2):21-9. doi: 10.1016/j.jns.2012.02.010. Epub 2012 Mar 3. Review.

PMID:
22385679
11.

Ascending monoaminergic systems alterations in Alzheimer's disease. translating basic science into clinical care.

Trillo L, Das D, Hsieh W, Medina B, Moghadam S, Lin B, Dang V, Sanchez MM, De Miguel Z, Ashford JW, Salehi A.

Neurosci Biobehav Rev. 2013 Sep;37(8):1363-79. doi: 10.1016/j.neubiorev.2013.05.008. Epub 2013 May 24. Review.

PMID:
23707776
12.

Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression.

Licznerski P, Duman RS.

Neuroscience. 2013 Oct 22;251:33-50. doi: 10.1016/j.neuroscience.2012.09.057. Epub 2012 Oct 2. Review.

13.

Neural correlates of dysfunctional emotion regulation in major depressive disorder. A systematic review of neuroimaging studies.

Rive MM, van Rooijen G, Veltman DJ, Phillips ML, Schene AH, Ruhé HG.

Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 2):2529-53. doi: 10.1016/j.neubiorev.2013.07.018. Epub 2013 Aug 6. Review.

PMID:
23928089
14.

Functional and structural MR imaging in neuropsychiatric disorders, Part 1: imaging techniques and their application in mild cognitive impairment and Alzheimer disease.

Mueller S, Keeser D, Reiser MF, Teipel S, Meindl T.

AJNR Am J Neuroradiol. 2012 Nov;33(10):1845-50. doi: 10.3174/ajnr.A2799. Epub 2011 Dec 15. Review.

15.

Untangling the Gordian knot of HIV, stress, and cognitive impairment.

Valdez AN, Rubin LH, Neigh GN.

Neurobiol Stress. 2016 Feb 11;4:44-54. eCollection 2016 Oct. Review.

16.

Structural and functional neuroimaging studies in major depressive disorder with psychotic features: a critical review.

Busatto GF.

Schizophr Bull. 2013 Jul;39(4):776-86. doi: 10.1093/schbul/sbt054. Epub 2013 Apr 24. Review.

17.

In pursuit of neuroimaging biomarkers to guide treatment selection in major depressive disorder: a review of the literature.

Lener MS, Iosifescu DV.

Ann N Y Acad Sci. 2015 May;1344:50-65. doi: 10.1111/nyas.12759. Epub 2015 Apr 8. Review.

PMID:
25854817
18.

Imaging phenotypes of major depressive disorder: genetic correlates.

Savitz JB, Drevets WC.

Neuroscience. 2009 Nov 24;164(1):300-30. doi: 10.1016/j.neuroscience.2009.03.082. Epub 2009 Apr 7. Review.

19.

Contemplating Alzheimer's disease and the contribution of white matter hyperintensities.

Brickman AM.

Curr Neurol Neurosci Rep. 2013 Dec;13(12):415. doi: 10.1007/s11910-013-0415-7. Review.

20.

Diffusion tensor imaging in normal aging and neuropsychiatric disorders.

Sullivan EV, Pfefferbaum A.

Eur J Radiol. 2003 Mar;45(3):244-55. Review.

PMID:
12595109

Supplemental Content

Support Center